secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADMA BIOLOGICS, INC. (ADMA)
CIK:        0001368514
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001140361-25-000871
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ADMA Biologics furnishes January 2025 corporate presentation without material updates
--------------------------------------------------------------------------------

- Corporate presentation furnished under Regulation FD; no specific financial results or guidance changes disclosed.
- Presentation expected to be used in meetings with investors, analysts, and strategic partners.
- Exhibit contains only a title slide; no operational or strategic updates provided.
- Company makes no admission as to materiality of information furnished.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1368514/000114036125000871/0001140361-25-000871-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1368514/000114036125000871/ef20041449_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-000871

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer